Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus Vaccine

NCT00641017 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

87

Enrollment

NIH

Sponsor class

Conditions

Parainfluenza
Virus Diseases

Interventions

BIOLOGICAL: rHPIV1 84/del170/942A, Lot PIV1 #104A vaccine
BIOLOGICAL: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]